Netherlands· NL-46c68dbb9154
Kanuma 2 mg/ml, concentraat voor oplossing voor infusie
A sebelipase alfa product containing sebelipase alfa, registered in Netherlands by Alexion Europe SAS. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Sebelipase alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB14 (sebelipase alfa), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Sebelipase alfa · ATC A16AB14
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- SEBELIPASE ALFA
- Manufacturer
- Alexion Europe SAS
- Country
- Netherlands (NL)
- ATC code
- A16AB14
- ATC class
- Sebelipase alfa
- Defined daily dose
- 5 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/15/1033
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sebelipase alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceKANUMA 2 mg/ml,solution à diluer pour perfusionALEXION EUROPE
- BelgiumKanuma 2 mg/mlAlexion Europe
- CanadaKANUMAALEXION PHARMA GMBH
- SwitzerlandKanuma 2 mg/ml, Konzentrat zur Herstellung einer InfusionslösungAlexion Pharma GmbH
- CzechiaKANUMAAlexion Europe SAS, Levallois-Perret
- SpainKANUMA 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONAlexion Europe Sas
- FinlandKANUMAAlexion Europe SAS
- United KingdomKanuma 20mg/10ml concentrate for solution for infusion vialsAlexion Pharma UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kanuma
- Liechtenstein · Kanuma
- Norway · Kanuma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/439a2249-1bac-4846-a20c-c4c995af33f8 GET /v1/drugs/439a2249-1bac-4846-a20c-c4c995af33f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/kanuma-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Sebelipase alfa",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp116674",
"excipients": [
"CITROENZUUR 1-WATER (E 330)",
"HUMAAN ALBUMINE",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER VOOR INJECTIE"
],
"substances": [
"SEBELIPASE ALFA"
],
"leaflet_url": null,
"authorised_at": "2015/08/28",
"procedure_number": "EMEA/H/C/004004",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/15/1033",
"additional_monitoring": "N"
}See everything about sebelipase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.